Legend Biotech (LEGN) Change in Account Payables (2019 - 2025)

Legend Biotech has reported Change in Account Payables for 7 years, with the latest figure at $24.3 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Account Payables rose 289.32% year-over-year to $24.3 million; the trailing twelve-month figure through Sep 2025 stood at $66.3 million (up 350.74% YoY), and the FY2024 full-year result was $14.1 million, up 128.01% from the prior year.
• Change in Account Payables for Q3 2025 stood at $24.3 million, up from $16.5 million in the prior quarter.
• The five-year high for Change in Account Payables was $41.9 million in Q4 2022, with the low at -$34.5 million in Q4 2023.
• Historically, Change in Account Payables has averaged $6.4 million across 5 years, with a median of $6.0 million in 2024.
• Annual changes were most pronounced in 2021 — Change in Account Payables soared 157597.82% — and 2023, when it sank 430.02%.
• Legend Biotech's Change in Account Payables stood at -$4.6 million in 2021, then soared by 1021.8% to $41.9 million in 2022, then tumbled by 182.21% to -$34.5 million in 2023, then jumped by 117.51% to $6.0 million in 2024, then surged by 302.04% to $24.3 million in 2025.
• The last three Change in Account Payables figures came in at $24.3 million (Q3 2025), $16.5 million (Q2 2025), and $19.5 million (Q1 2025), per Business Quant data.